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We welcome the paper by Morris and colleagues on the
prevalence of microcephaly in Europe.1 The authors state that
increases in prevalence such as expected with Zika virus in a
non-endemic region would be unlikely to be detected in Europe
through routine surveillance.
As a newly identified teratogen, Zika requires global and
dedicated tools to allow comprehensive characterisation of the
risks associated with its materno-fetal transmission. Nearly a
year after the first reported increase in microcephaly in Brazil,2
the magnitude of the risks of materno-fetal transmission and
the associated potential cofactors remain unclear.
Case reports and congenital anomaly surveillance systems are
indispensable tools in detecting new teratogens and have been
effective in Brazil’s Zika outbreak. However, since these tools
will probably not provide global information or allow in-depth
comprehension of the link between a teratogen and its risks, we
need epidemiological studies, such as case-control studies and
cohort studies with appropriate follow-up.
To facilitate these studies we have launched an international
web registry,3 enrolling pregnant women, prospectively and
anonymously, at any gestational age as soon as Zika exposure
is suspected (eg, mosquito bite, unprotected sex) and ideally
before any additional screening (a prospective registry).
Follow-up information on other risk factors and on pregnancy,
fetal, and neonatal outcomes is gathered after birth. Any
healthcare provider supporting the registry by providing well
documented exposures will be regarded as a collaborator of the
registry in any future peer reviewed scientific publication (see
https://epgl.unige.ch/zika-in-pregnancy-registry/). The collected
data will be available to research groups that have a clear,
non-redundant research question and approval from a biomedical
research ethics committee.
We hope that this centralised dataset of shared information will
allow research to progress in acquiring a comprehensive
characterisation of the risks associated with Zika materno-fetal
transmission.
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